These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28117704)

  • 21. Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration.
    Haapasalo K; Wollman AJM; de Haas CJC; van Kessel KPM; van Strijp JAG; Leake MC
    FASEB J; 2019 Mar; 33(3):3807-3824. PubMed ID: 30509126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering of the LukS-PV and LukF-PV subunits of Staphylococcus aureus Panton-Valentine leukocidin for diagnostic and therapeutic applications.
    Okolie CE; Cockayne A; Penfold C; James R
    BMC Biotechnol; 2013 Nov; 13():103. PubMed ID: 24252611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine72 residue at the bottom of rim domain in LukF crucial for the sequential binding of the staphylococcal gamma-hemolysin to human erythrocytes.
    Yokota K; Kamio Y
    Biosci Biotechnol Biochem; 2000 Dec; 64(12):2744-7. PubMed ID: 11210152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential binding of LukF of staphylococcal gamma-hemolysin followed by the binding of H gamma II for the hemolysis of human erythrocytes.
    Ozawa T; Kaneko J; Kamio Y
    Biosci Biotechnol Biochem; 1995 Jun; 59(6):1181-3. PubMed ID: 7613012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.
    Karauzum H; Adhikari RP; Sarwar J; Devi VS; Abaandou L; Haudenschild C; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Warfield KL; Shulenin S; Aman MJ
    PLoS One; 2013; 8(6):e65384. PubMed ID: 23762356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of leucotoxin S component: new insight into the Staphylococcal beta-barrel pore-forming toxins.
    Guillet V; Roblin P; Werner S; Coraiola M; Menestrina G; Monteil H; Prévost G; Mourey L
    J Biol Chem; 2004 Sep; 279(39):41028-37. PubMed ID: 15262988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discoupling the Ca(2+)-activation from the pore-forming function of the bi-component Panton-Valentine leucocidin in human PMNs.
    Baba Moussa L; Werner S; Colin DA; Mourey L; Pédelacq JD; Samama JP; Sanni A; Monteil H; Prévost G
    FEBS Lett; 1999 Nov; 461(3):280-6. PubMed ID: 10567712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gamma-hemolysin locus of Staphylococcus aureus comprises three linked genes, two of which are identical to the genes for the F and S components of leukocidin.
    Cooney J; Kienle Z; Foster TJ; O'Toole PW
    Infect Immun; 1993 Feb; 61(2):768-71. PubMed ID: 8423103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid detection of Panton-Valentine leukocidin-positive Staphylococcus aureus by real-time PCR targeting the lukS-PV gene.
    Reischl U; Tuohy MJ; Hall GS; Procop GW; Lehn N; Linde H
    Eur J Clin Microbiol Infect Dis; 2007 Feb; 26(2):131-5. PubMed ID: 17256113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequencing of leucocidin R from Staphylococcus aureus P83 suggests that staphylococcal leucocidins and gamma-hemolysin are members of a single, two-component family of toxins.
    Supersac G; Prevost G; Piemont Y
    Infect Immun; 1993 Feb; 61(2):580-7. PubMed ID: 8423088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections.
    Hamilton SM; Bryant AE; Carroll KC; Lockary V; Ma Y; McIndoo E; Miller LG; Perdreau-Remington F; Pullman J; Risi GF; Salmi DB; Stevens DL
    Clin Infect Dis; 2007 Dec; 45(12):1550-8. PubMed ID: 18190315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delta Hemolysin and Phenol-Soluble Modulins, but Not Alpha Hemolysin or Panton-Valentine Leukocidin, Induce Mast Cell Activation.
    Hodille E; Cuerq C; Badiou C; Bienvenu F; Steghens JP; Cartier R; Bes M; Tristan A; Plesa A; Le VT; Diep BA; Lina G; Dumitrescu O
    Front Cell Infect Microbiol; 2016; 6():180. PubMed ID: 28018862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The staphylococcal pore-forming leukotoxins open Ca2+ channels in the membrane of human polymorphonuclear neutrophils.
    Staali L; Monteil H; Colin DA
    J Membr Biol; 1998 Apr; 162(3):209-16. PubMed ID: 9543493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocidal toxins of staphylococci.
    Szmigielski S; Prévost G; Monteil H; Colin DA; Jeljaszewicz J
    Zentralbl Bakteriol; 1999 Apr; 289(2):185-201. PubMed ID: 10360319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome.
    Holzinger D; Gieldon L; Mysore V; Nippe N; Taxman DJ; Duncan JA; Broglie PM; Marketon K; Austermann J; Vogl T; Foell D; Niemann S; Peters G; Roth J; Löffler B
    J Leukoc Biol; 2012 Nov; 92(5):1069-81. PubMed ID: 22892107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploration of compounds to inhibit the Panton-Valentine leukocidin of Staphylococcus aureus.
    Grebe T; Sarkari MT; Cherkaoui A; Schaumburg F
    Med Microbiol Immunol; 2024 Sep; 213(1):19. PubMed ID: 39297970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the essential amino acid residues in lukS for the hemolytic activity of staphylococcal leukocidin towards rabbit erythrocytes.
    Nariya H; Shimatani A; Tomita T; Kamio Y
    Biosci Biotechnol Biochem; 1997 Dec; 61(12):2095-9. PubMed ID: 9438990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LukS-PV, a component of Panton-Valentine leukocidin, exerts potent activity against acute myeloid leukemia in vitro and in vivo.
    Shan W; Bu S; Zhang C; Zhang S; Ding B; Chang W; Dai Y; Shen J; Ma X
    Int J Biochem Cell Biol; 2015 Apr; 61():20-8. PubMed ID: 25601295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus.
    Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL
    Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of a LukS-PV mutant of a staphylococcal Panton-Valentine leukocidin component having a high LukS-like function.
    Shimatani A; Kaneko J; Tomita T; Kamio Y
    Biosci Biotechnol Biochem; 1999 Oct; 63(10):1828-30. PubMed ID: 10586512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.